<DOC>
	<DOCNO>NCT01406145</DOCNO>
	<brief_summary>This study intend determine safety tolerability ASP0777 subject Alzheimer 's Disease ( AD ) take stable dose donepezil .</brief_summary>
	<brief_title>A Study Safety Tolerability ASP0777 Subjects With Alzheimer 's Disease ( AD ) Taking Stable Dose Donepezil</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Subject MiniMental Status Exam score 1826 Subject diagnosis `` probable '' Alzheimer 's Disease Subject use donepezil least 3 month stable dose least 6 week prior screen Subject reliable adult reside him/her outpatient portion study Subject medically stable Subject adequate cognitive , hearing , vision , language skill Subject able ingest oral tablet Subject receive investigational product another clinical study postmarketing clinical study within past 3 month Subject clinically significant abnormal laboratory test Subject female pregnant , lactate childbearing potential refuse use form contraception study Subject history drug allergy intolerance memantine relate compound Subject currently use antidementia drug ( except donepezil ) use drug within last 4 week Subject score 2 item 16 Cornell Scale Depression Dementia ( CSDD ) overall CSDD score &gt; 10 Subject use offlabel medicine , nonmedicinal compound , dietary aids/food supplement improve cognition stable dose least 4 week prior Screening and/or anticipate change dose regimen study Subject history drug alcohol abuse within past 12 month subject consumes &gt; 1 drink alcohol daily , unable refrain alcohol study Subject current smoker recently quit smoking ( within past 12 month ) Subject clinically significant medical condition unstable likely become unstable course study Subject history seizure , febrile seizure infancy Subject history repeat fall within past 6 month Subject major psychiatric illness receive treatment symptom major psychiatric illness within past 1 year . Mild psychiatric disorder allowable</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>ASP0777</keyword>
</DOC>